BeOne Medicines Ltd.·4

Jun 25, 5:08 PM ET

Wang Xiaodong 4

4 · BeOne Medicines Ltd. · Filed Jun 25, 2025

Insider Transaction Report

Form 4
Period: 2025-06-24
Wang Xiaodong
DirectorOther
Transactions
  • Sale

    American Depositary Shares

    2025-06-24$263.50/sh300$79,0501,707 total
  • Sale

    American Depositary Shares

    2025-06-24$265.35/sh1,100$291,888607 total
  • Sale

    American Depositary Shares

    2025-06-24$267.81/sh100$26,7810 total
  • Sale

    American Depositary Shares

    2025-06-24$266.57/sh507$135,149100 total
Holdings
  • Ordinary Shares

    5,154,770
  • Ordinary Shares

    (indirect: See Footnote)
    3,953,100
  • Ordinary Shares

    (indirect: See Footnote)
    1,025,063
  • Ordinary Shares

    (indirect: See Footnote)
    50
Footnotes (8)
  • [F1]These securities are held by a family trust, the beneficiaries of which are the Reporting Person's family members, for which the Reporting Person disclaims beneficial ownership.
  • [F2]These securities are held by Wang Investment LLC, of which 99% of the limited liability company interest is owned by two grantor retained annuity trusts, of which the Reporting Person's wife is a trustee, for which the Reporting Person disclaims beneficial ownership.
  • [F3]These securities are held by the spouse of the Reporting Person.
  • [F4]Each American Depositary Share represents 13 Ordinary Shares.
  • [F5]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on August 12, 2024.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.40 to $263.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.02 to $265.86, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.27 to $266.95, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

Documents

1 file
  • 4
    wk-form4_1750885680.xmlPrimary

    FORM 4